Industry & Business

Diaceutics announces 30 jobs on back of 60% revenue growth

 Breaking News
  • International Appetite Fed at First Birmingham Brexit Event With so many questions addressed at the first in a series of dedicated Brexit Seminars held in Birmingham, interest amongst its international delegation remains high, with the second Brexit Seminar planned for Wednesday 27th June 2018.   Sectors and countries represented at February’s event encompassed food businesses and non-food importers, Embassies, logistics providers and consultants from the [...]...
  • TSM’s Shane O’Callaghan: ‘The key to IIoT is to keep it beautifully simple’ The rise of industry 4.0 and the industrial internet of things presents lots of unexpected business opportunities, says TSM Control Systems’ Shane O’Callaghan. Shane O’Callaghan is business unit leader of Insight at TSM Control Systems. He joined the company in 2008 as a business analyst and then became sales manager for Europe. TSM Control Systems was founded in [...]...
  • Fine Grain Property acquires 60,000 square feet office development in Cork Airport Business Park New Year, new acquisition! Fine Grain Property is delighted to announce it has acquired a 60,000 square feet office development in Cork Airport Business Park. Plans are already afoot to carry out some important improvements to the Building that will benefit its existing tenants, including Aviva, Aon Hewitt, JLT and Genesis. In addition, a significant [...]...
  • Irish Technology Sector Has Overtaken Agriculture With 130,000 people now employed, the technology sector has overtaken agriculture as Ireland’s largest industry, according to Ken Finnegan (pictured above), formerly Chief Technology and Research Advisor for IDA Technology Ireland and now Director of Technology & Innovation for the about to be opened Harbour Innovation Campus at Dún Laoghaire. About 15,000 of these tech [...]...
  • 2018 Research and Innovation Conference & Exhibition Provides Insight into the R&D and Innovation Ecosystem in Ireland Designed to foster collaboration between industry, academia and government agencies, the 2018 Research and Innovation Conference & Exhibition attracted over 1,000 visitors from across the major industrial sectors in Ireland to the Citywest Hotel, Dublin, on Wednesday, March 14th. The visitors who braved the inclement weather were able to meet with the key organisations that are [...]...

Diaceutics announces 30 jobs on back of 60% revenue growth

Diaceutics announces 30 jobs on back of 60% revenue growth
April 14
09:00 2017

Irish data insights and solutions company Diaceutics has announces 30 new jobs which will facilitate further international growth for Diaceutics and allow it to expand its presence in all of its key markets including the US, Europe, Asia and South America.

Diaceutics allows pharmaceutical companies to reach more patients that need to be on specific – and often life-saving – drugs by helping them better understand testing for specific illnesses and biomarkers. The company forecasts that the precision medicine market in which it operates will grow from €1.4 billion today to €4 billion by 2020.

Since inception, Diaceutics has been involved in more than 200 drug launches and currently has a 60% share in the top 10 global markets. It currently counts 26 out of the world’s top 30 pharmaceutical companies as clients and provides oversight of testing in 23 markets.

The 30 extra jobs over the next two years are in areas including global operations, marketing and data analysis and will bring its global team up to 100. The jobs will be created at its global headquarters in Ireland, US headquarters in Parsippany, New Jersey as well as in satellite offices in Asia and South America.

Peter Keeling, CEO, Diaceutics, said: “Testing is now at the heart of pharmaceutical companies’ ability to identify the right patients for their new therapies. We are uniquely positioned to provide the global testing perspective that allows this identification and treatment of patients who will benefit from specific and often life-saving drugs.

“To put the importance of what we do into context, we have put structures in place that each year help 48,000 cancer patients in the US and EU get biomarker testing and therefore potentially gain access to the right drug for their specific condition.

“Diaceutics has been growing by an average of 60% per annum for the past three years and we expect that growth trajectory to continue as our addressable market is doubling. To facilitate that, we will require a number of new team members in key roles over the next two years.

“Some 70% of new cancer drug launches will be diagnostics-dependent in the next five years. Pharma will be relying on us to show them how they can maximise their market share in what is going to become an increasingly profitable area – and a hugely beneficial one to patients. Diaceutics has positioned itself as a key partner for pharma as it capitalises on the unique opportunity to use diagnostics intelligence to successfully roll out precision medicine.”

About Author



Related Articles

New Subscriber

Subscribe Here


National Manufacturing Conference & Exhibition 2018

NIBRT Springboard Success Stories

Upcoming Events

  • No upcoming events
AEC v1.0.4